The Breast Cancer Index Impacts Physicians’ Decision to Extend Endocrine Therapy for HR+ Early-Stage Disease
Incorporating the Breast Cancer Index test assay into practice affected clinicians’ decision to offer endocrine therapy in HR+ early-stage disease.